{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:55:40Z","timestamp":1790952940829,"version":"4.1.0"},"reference-count":34,"publisher":"Pleiades Publishing Ltd","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1134\/s0006297926601504","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:31:03Z","timestamp":1790951463000},"page":"1587-1595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Newly Identified FDA-Approved MTAs: Opportunities for Antimicrobial Repurposing?"],"prefix":"10.1134","volume":"91","author":[{"given":"Amira Zhor Rim","family":"Zinai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mapenda","family":"Gaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriia E.","family":"Baksheeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Fenollar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp O.","family":"Tsvetkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Mediannikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"3089_CR1","doi-asserted-by":"publisher","unstructured":"Straube, A. (2011) Microtubule Dynamics: Methods and Protocols, Humana Press, Totowa, NJ, \nhttps:\/\/doi.org\/10.1007\/978-1-61779-252-6.","DOI":"10.1007\/978-1-61779-252-6"},{"key":"3089_CR2","doi-asserted-by":"publisher","first-page":"17485","DOI":"10.1021\/acs.jmedchem.5c01008","volume":"68","author":"V. Baksheeva","year":"2025","unstructured":"Baksheeva, V., La Rocca, R., Allegro, D., Derviaux, C., Pasquier, E., Roche, P., Morelli, X., Devred, F., Golovin, A. V., and Tsvetkov, P. O. (2025) NanoDSF screening for anti-tubulin agents uncovers new structure-activity insights, J. Med. Chem., 68, 17485-17498, \nhttps:\/\/doi.org\/10.1021\/acs.jmedchem.5c01008.","journal-title":"J. Med. Chem."},{"key":"3089_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.tcb.2019.07.004","volume":"29","author":"S. Bodakuntla","year":"2019","unstructured":"Bodakuntla, S., Jijumon, A. S., Villablanca, C., Gonzalez-Billault, C., and Janke, C. (2019) Microtubule-associated proteins: structuring the cytoskeleton, Trends Cell Biol., 29, 804-819, \nhttps:\/\/doi.org\/10.1016\/j.tcb.2019.07.004.","journal-title":"Trends Cell Biol."},{"key":"3089_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022608","volume":"10","author":"H. V. Goodson","year":"2018","unstructured":"Goodson, H. V., and Jonasson, E. M. (2018) Microtubules and microtubule-associated proteins, Cold Spring Harb. Perspect. Biol., 10, a022608, \nhttps:\/\/doi.org\/10.1101\/cshperspect.a022608.","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"3089_CR5","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.biochi.2011.09.011","volume":"94","author":"P. O. Tsvetkov","year":"2012","unstructured":"Tsvetkov, P. O., Makarov, A. A., Malesinski, S., Peyrot, V., and Devred, F. (2012) New insights into tau-microtubules interaction revealed by isothermal titration calorimetry, Biochimie, 94, 916-919, \nhttps:\/\/doi.org\/10.1016\/j.biochi.2011.09.011.","journal-title":"Biochimie"},{"key":"3089_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11101-013-9302-8","volume":"13","author":"P. Barbier","year":"2014","unstructured":"Barbier, P., Tsvetkov, P. O., Breuzard, G., and Devred, F. (2014) Deciphering the molecular mechanisms of anti-tubulin plant derived drugs, Phytochem. Rev., 13, 157-169, \nhttps:\/\/doi.org\/10.1007\/s11101-013-9302-8.","journal-title":"Phytochem. Rev."},{"key":"3089_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225650","volume":"13","author":"L. Wordeman","year":"2021","unstructured":"Wordeman, L., and Vicente, J. J. (2021) Microtubule targeting agents in disease: classic drugs, novel roles, Cancers, 13, 5650, \nhttps:\/\/doi.org\/10.3390\/cancers13225650.","journal-title":"Cancers"},{"key":"3089_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1517\/13543776.2011.545349","volume":"21","author":"B. P. Chatterji","year":"2011","unstructured":"Chatterji, B. P., Jindal, B., Srivastava, S., and Panda, D. (2011) Microtubules as antifungal and antiparasitic drug targets, Expert Opin. Ther. Pat., 21, 167-186, \nhttps:\/\/doi.org\/10.1517\/13543776.2011.545349.","journal-title":"Expert Opin. Ther. Pat."},{"key":"3089_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00044-019-02352-2","volume":"28","author":"H. Guo","year":"2019","unstructured":"Guo, H., Li, X., Guo, Y., and Zhen, L. (2019) An overview of tubulin modulators deposited in Protein Data Bank, Med. Chem. Res., 28, 927-937, \nhttps:\/\/doi.org\/10.1007\/s00044-019-02352-2.","journal-title":"Med. Chem. Res."},{"key":"3089_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071721","volume":"12","author":"D. Zhang","year":"2020","unstructured":"Zhang, D., and Kanakkanthara, A. (2020) Beyond the paclitaxel and vinca alkaloids: next generation of plant-derived microtubule-targeting agents with potential anticancer activity, Cancers, 12, 1721, \nhttps:\/\/doi.org\/10.3390\/cancers12071721.","journal-title":"Cancers"},{"key":"3089_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2020.151075","volume":"99","author":"V. \u010cerm\u00e1k","year":"2020","unstructured":"\u010cerm\u00e1k, V., Dost\u00e1l, V., Jel\u00ednek, M., Libusov\u00e1, L., Kov\u00e1\u0159, J., R\u00f6sel, D., and Br\u00e1bek, J. (2020) Microtubule-targeting agents and their impact on cancer treatment, Eur. J. Cell Biol., 99, 151075, \nhttps:\/\/doi.org\/10.1016\/j.ejcb.2020.151075.","journal-title":"Eur. J. Cell Biol."},{"key":"3089_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0022-2836(76)90293-X","volume":"102","author":"K. Weber","year":"1976","unstructured":"Weber, K., Wehland, J., and Herzog, W. (1976) Griseofulvin interacts with microtubules both in vivo and in vitro, J. Mol. Biol., 102, 817-829, \nhttps:\/\/doi.org\/10.1016\/0022-2836(76)90293-X.","journal-title":"J. Mol. Biol."},{"key":"3089_CR13","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1128\/am.21.5.944-945.1971","volume":"21","author":"W. A. Maxwell","year":"1971","unstructured":"Maxwell, W. A., and Brody, G. (1971) Antifungal activity of selected benzimidazole compounds, Appl. Microbiol., 21, 944-945, \nhttps:\/\/doi.org\/10.1128\/am.21.5.944-945.1971.","journal-title":"Appl. Microbiol."},{"key":"3089_CR14","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1128\/AAC.48.5.1739-1748.2004","volume":"48","author":"T. Kiso","year":"2004","unstructured":"Kiso, T., Fujita, K.-I., Ping, X., Tanaka, T., and Taniguchi, M. (2004) Screening for microtubule-disrupting antifungal agents by using a mitotic-arrest mutant of Aspergillus nidulans and novel action of phenylalanine derivatives accompanying tubulin loss, Antimicrob. Agents Chemother., 48, 1739-1748, \nhttps:\/\/doi.org\/10.1128\/AAC.48.5.1739-1748.2004.","journal-title":"Antimicrob. Agents Chemother."},{"key":"3089_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00069-19","volume":"33","author":"E. L. Berkow","year":"2020","unstructured":"Berkow, E. L., Lockhart, S. R., and Ostrosky-Zeichner, L. (2020) Antifungal susceptibility testing: current approaches, Clin. Microbiol. Rev., 33, e00069-19, \nhttps:\/\/doi.org\/10.1128\/CMR.00069-19.","journal-title":"Clin. Microbiol. Rev."},{"key":"3089_CR16","doi-asserted-by":"publisher","unstructured":"Bhargav, H. S., Shastri, S. D., Poornav, S. P., Darshan, K. M., and Nayak, M. M. (2016) Measurement of the zone of inhibition of an antibiotic, in: Proc. 2016 IEEE 6th Int. Conf. Adv. Comput. (IACC), pp. 409-414, \nhttps:\/\/doi.org\/10.1109\/IACC.2016.82.","DOI":"10.1109\/IACC.2016.82"},{"key":"3089_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-025-01917-2","volume":"15","author":"M. Gaye","year":"2025","unstructured":"Gaye, M., Zinai, A. Z. R., Armstrong, N., Herbette, G., Monnier, V., Bassene, H., Diatta, G., Sambou, M., Sokhna, C., Raoult, D., Fenollar, F., and Mediannikov, O. (2025) Antibacterial activity of fungus comb extracts from Senegalese fungus-farming termites, AMB Express, 15, 117, \nhttps:\/\/doi.org\/10.1186\/s13568-025-01917-2.","journal-title":"AMB Express"},{"key":"3089_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S. Pushpakom","year":"2019","unstructured":"Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., Norris, A., Sanseau, P., Cavalla, D., and Pirmohamed, M. (2019) Drug repurposing: progress, challenges and recommendations, Nat. Rev. Drug Discov., 18, 41-58, \nhttps:\/\/doi.org\/10.1038\/nrd.2018.168.","journal-title":"Nat. Rev. Drug Discov."},{"key":"3089_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"T. T. Ashburn","year":"2004","unstructured":"Ashburn, T. T., and Thor, K. B. (2004) Drug repositioning: identifying and developing new uses for existing drugs, Nat. Rev. Drug Discov., 3, 673-683, \nhttps:\/\/doi.org\/10.1038\/nrd1468.","journal-title":"Nat. Rev. Drug Discov."},{"key":"3089_CR20","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","volume":"24","author":"V. Parvathaneni","year":"2019","unstructured":"Parvathaneni, V., Kulkarni, N. S., Muth, A., and Gupta, V. (2019) Drug repurposing: a promising tool to accelerate the drug discovery process, Drug Discov. Today, 24, 2076-2085, \nhttps:\/\/doi.org\/10.1016\/j.drudis.2019.06.014.","journal-title":"Drug Discov. Today"},{"key":"3089_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10096-003-0947-x","volume":"22","author":"J. Afeltra","year":"2003","unstructured":"Afeltra, J., and Verweij, P. E. (2003) Antifungal activity of nonantifungal drugs, Eur. J. Clin. Microbiol. Infect. Dis., 22, 397-407, \nhttps:\/\/doi.org\/10.1007\/s10096-003-0947-x.","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"3089_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.mycmed.2019.07.004","volume":"29","author":"D. C. Moraes","year":"2019","unstructured":"Moraes, D. C., and Ferreira-Pereira, A. (2019) Insights on the anticandidal activity of non-antifungal drugs, J. Mycol. Med., 29, 253-259, \nhttps:\/\/doi.org\/10.1016\/j.mycmed.2019.07.004.","journal-title":"J. Mycol. Med."},{"key":"3089_CR23","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1093\/gbe\/evu187","volume":"6","author":"P. Findeisen","year":"2014","unstructured":"Findeisen, P., M\u00fchlhausen, S., Dempewolf, S., Hertzog, J., Zietlow, A., Carlomagno, T., and Kollmar, M. (2014) Six subgroups and extensive recent duplications characterize the evolution of the eukaryotic tubulin protein family, Genome Biol. Evol., 6, 2274-2288, \nhttps:\/\/doi.org\/10.1093\/gbe\/evu187.","journal-title":"Genome Biol. Evol."},{"key":"3089_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1128\/CMR.12.1.40","volume":"12","author":"D. J. Sheehan","year":"1999","unstructured":"Sheehan, D. J., Hitchcock, C. A., and Sibley, C. M. (1999) Current and emerging azole antifungal agents, Clin. Microbiol. Rev., 12, 40-79, \nhttps:\/\/doi.org\/10.1128\/CMR.12.1.40.","journal-title":"Clin. Microbiol. Rev."},{"key":"3089_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26144213","volume":"26","author":"P. Sharma","year":"2021","unstructured":"Sharma, P., LaRosa, C., Antwi, J., Govindarajan, R., and Werbovetz, K. A. (2021) Imidazoles as potential anticancer agents: an update on recent studies, Molecules, 26, 4213, \nhttps:\/\/doi.org\/10.3390\/molecules26144213.","journal-title":"Molecules"},{"key":"3089_CR26","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/S0022-5347(05)67875-5","volume":"163","author":"M. V. Blagosklonny","year":"2000","unstructured":"Blagosklonny, M. V., Dixon, S. C., and Figg, W. D. (2000) Efficacy of microtubule-active drugs followed by ketoconazole in human metastatic prostate cancer cell lines, J. Urol., 163, 1022-1026, \nhttps:\/\/doi.org\/10.1016\/S0022-5347(05)67875-5.","journal-title":"J. Urol."},{"key":"3089_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111732","volume":"184","author":"L. Li","year":"2019","unstructured":"Li, L., Quan, D., Chen, J., Ding, J., Zhao, J., Lv, L., and Chen, J. (2019) Design, synthesis, and biological evaluation of 1-substituted-2-aryl imidazoles targeting tubulin polymerization as potential anticancer agents, Eur. J. Med. Chem., 184, 111732, \nhttps:\/\/doi.org\/10.1016\/j.ejmech.2019.111732.","journal-title":"Eur. J. Med. Chem."},{"key":"3089_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1021\/acsinfecdis.7b00157","volume":"4","author":"M. C. Montoya","year":"2018","unstructured":"Montoya, M. C., DiDone, L., Heier, R. F., Meyers, M. J., and Krysan, D. J. (2018) Antifungal phenothiazines: optimization, characterization of mechanism, and modulation of neuroreceptor activity, ACS Infect. Dis., 4, 499-507, \nhttps:\/\/doi.org\/10.1021\/acsinfecdis.7b00157.","journal-title":"ACS Infect. Dis."},{"key":"3089_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","volume":"15","author":"C. Roder","year":"2015","unstructured":"Roder, C., and Thomson, M. J. (2015) Auranofin: repurposing an old drug for a golden new age, Drugs R D, 15, 13-20, \nhttps:\/\/doi.org\/10.1007\/s40268-015-0083-y.","journal-title":"Drugs R D"},{"key":"3089_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1065962","volume":"12","author":"J. Lin","year":"2022","unstructured":"Lin, J., Xiao, X., Liang, Y., Zhao, H., Yu, Y., Yuan, P., Lu, S., and Ding, X. (2022) Repurposing non-antifungal drugs auranofin and pentamidine in combination as fungistatic antifungal agents against Candida albicans, Front. Cell. Infect. Microbiol., 12, 1065962, \nhttps:\/\/doi.org\/10.3389\/fcimb.2022.1065962.","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"3089_CR31","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1128\/AAC.44.4.848-852.2000","volume":"44","author":"C. M. Kunin","year":"2000","unstructured":"Kunin, C. M., and Ellis, W. Y. (2000) Antimicrobial activities of mefloquine and a series of related compounds, Antimicrob. Agents Chemother., 44, 848-852, \nhttps:\/\/doi.org\/10.1128\/AAC.44.4.848-852.2000.","journal-title":"Antimicrob. Agents Chemother."},{"key":"3089_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1100249","volume":"13","author":"C. Santana-Molina","year":"2023","unstructured":"Santana-Molina, C., Saz-Navarro, D. M., and Devos, D. P. (2023) Early origin and evolution of the FtsZ\/tubulin protein family, Front. Microbiol., 13, 1100249, \nhttps:\/\/doi.org\/10.3389\/fmicb.2022.1100249.","journal-title":"Front. Microbiol."},{"key":"3089_CR33","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1021\/acsinfecdis.9b00055","volume":"5","author":"K. D. Kusuma","year":"2019","unstructured":"Kusuma, K. D., Payne, M., Ung, A. T., Bottomley, A. L., and Harry, E. J. (2019) FtsZ as an antibacterial target: status and guidelines for progressing this avenue, ACS Infect. Dis., 5, 1279-1294, \nhttps:\/\/doi.org\/10.1021\/acsinfecdis.9b00055.","journal-title":"ACS Infect. Dis."},{"key":"3089_CR34","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/febs.15489","volume":"288","author":"H. Han","year":"2021","unstructured":"Han, H., Wang, Z., Li, T., Teng, D., Mao, R., Hao, Y., Yang, N., Wang, X., and Wang, J. (2021) Recent progress of bacterial FtsZ inhibitors with a focus on peptides, FEBS J., 288, 1091-1106, \nhttps:\/\/doi.org\/10.1111\/febs.15489.","journal-title":"FEBS J."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926601504.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297926601504","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926601504.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:31:04Z","timestamp":1790951464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297926601504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3089"],"URL":"https:\/\/doi.org\/10.1134\/s0006297926601504","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      This work does not contain any studies involving human and animal subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}